EMERALD: elacestrant vs physicians choice in ER+/HER2- breast cancer VJOncology 1:27 2 years ago 749 Скачать Далее
Elacestrant significantly prolongs PFS for ER+/HER2- metastatic BC without prior chemotherapy pts ecancer 2:06 2 years ago 694 Скачать Далее
EMERALD: elacestrant vs. SOC for patients with ER+ HER2- metastatic breast cancer VJOncology 2:03 2 years ago 1 637 Скачать Далее
Elacestrant shows improved PFS in patients with ER-positive/HER2-negative metastatic breast cancer ecancer 3:24 1 year ago 365 Скачать Далее
EMERALD Study lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Aditya Bardia OncBrothers: Practice-Changing Cancer Discussions 16:10 1 year ago 862 Скачать Далее
EMERALD lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Virginia Kaklamani OncBrothers: Practice-Changing Cancer Discussions 17:11 1 year ago 517 Скачать Далее
Update of EMERALD by duration of CDK4/6i in metastatic setting: elacestrant v SoC in ER+/HER2- mBC VJOncology 0:46 1 year ago 281 Скачать Далее
Overview of Clinical Data of SERDs & Their Place in Treatment Landscape COR2ED The Heart of Medical Education 18:40 10 months ago 3 412 Скачать Далее
Phase I Study of Investigational Drug Elacestrant (RAD1901) Cancer Therapy Advisor 3:20 7 years ago 338 Скачать Далее
FDA approves Elacestrant (Orserdu) for ER-positive, HER2-negative, ESR1-mutated breast cancer medXclusive Learning 0:50 1 year ago 876 Скачать Далее
Elacestrant: A New Weapon Against Advanced Estrogen Receptor-Positive Breast Cancer Pharmacology Insights 2:37 3 months ago 109 Скачать Далее
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer VJOncology 3:01 2 years ago 209 Скачать Далее
What EMERALD Phase III trial could mean for breast cancer patients | Virginia Kaklamani, MD UT Health San Antonio MD Anderson Cancer Center 1:01 1 year ago 403 Скачать Далее
Breast Cancer Breakthroughs: Dr. Donald McDonnell explains how elacestrant was discovered in his lab Susan G. Komen® 3:59 1 month ago 29 Скачать Далее
New Stage 4 Breast Cancer Cure? | Dr Liz O'Riordan Dr Liz O'Riordan 5:06 1 year ago 21 461 Скачать Далее
GS2-02: "Elacestrant, an oral selective estrogen receptor degrader (SERD), vs investigator’s..." San Antonio Breast Cancer Symposium 20:37 1 year ago 582 Скачать Далее
ER+ metastatic breast cancer: Elacestrant and beyond COR2ED The Heart of Medical Education 5:30 3 months ago 108 Скачать Далее
2023 Updates In Metastatic Breast Cancer Treatment Metastatic Breast Cancer - Tools and Togetherness 44:21 1 year ago 2 345 Скачать Далее
#therapy for breast cancer #cancer #breastcancer #fdaapproved drugs 2023 #Orserdu#shorts Clinical pathway 0:52 1 year ago 126 Скачать Далее
